Diabetes Health in the News Podcast: Stem Cells Treatment Aid in Diabetes Foot Ulcers

https://media.blubrry.com/diabeteshealthpodcast/p/www.diabeteshealth.com/wp-content/uploads/2016/02/Jan-24_-2016_-4_25_35-PM.m4aPodcast: Play in new window | DownloadClick here to listen to today’s Diabetes Health in the News Podcast! Researchers recently examined the relationship between stem cells and the healing of diabetic foot ulcers. Physicians at the University of Maryland School of Medicine in Baltimore, collected blood samples and wound margins from 100 patients over the course of eight weeks. With this information, they examined stem/progenitor

Read more

Warning Letters Issued to Illegally Sold Diabetes Treatments

Recently, FDA launched an initiative to counter these illegally sold products aimed at consumers who have diabetes. In addition to evaluating numerous consumer complaints, FDA surveyed the marketplace for illegally sold products promising to treat diabetes and its complications. In July 2013, FDA issued letters warning 15 companies about selling products for diabetes in violation of federal law. These products are sold as dietary supplements;

Read more

Penny Hildreth: Finally Facing Diabetes

It was more than two decades ago, and Penny Hildreth was already feeling overwhelmed by life when she learned that she had type 1 diabetes. She was pregnant with her second child and worried about the baby’s safety after a car accident that had left Hildreth with a broken collarbone, a broken rib, and a punctured spleen. It was the spleen injury that ultimately led

Read more

Israeli Biotech Company Takes Novel Approach to Diabetic Ulcer Treatment

An Israeli biotech company’s cell therapy, designed to treat hard-to-heal diabetic ulcers, is now in phase 3 testing in the United States. The company, Macrocure, reports that its product, CureXcell, demonstrated impressive success rates at Israel’s largest HMO. The Israeli trial, called a “Real Life” phase 4 trial, was conducted with 131 subjects at seven clinics operated by Clalit Health Service. Macrocure announced the trial

Read more